"The Company currently plans to release its first, second, and third quarter quarterly reports at the same time."
We need updates ASAP on:
financial reports to regain compliance past convertible debt issues cash management to handle commercial notes properly announced restructuring operations
Could Kiwa Biotech be restricted in issuing new shares to Chinese investors without first regaining filing compliance (losing the delinquent status) and hopefully establishing a reasonable market value?
Last filing on June 1st. Next week, Dec 1st, will be 6 months waiting for a filing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.